KORU Medical Q3 2026 slides: margin expansion drives profitability turn

KORU Medical Systems, Inc. (KRMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA MAHWAH, NJ – November 10, 2026 – KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical t

SK Hynix (SKHY) fell 6% at Wednesday's close, down 12% since July. Foreign investors sold 173.2 trillion KRW in Samsung and SKHynix stocks. Park Yeon-joo of Mirae Asset Securities attributed this to AI investment concerns and KOSPI volatility. KORU, an ETF, dropped 12% but is up 42% in 2026. Retail sentiment on Stocktwits turned from 'extremely bullish' to 'bullish'.

KORU Medical Systems (KRMD) reported Q2 PST revenue of $0.6M, down 35% year over year, citing lower clinical-trial orders and timing. Gross margin rose to 65.1% from 63.5%. The company narrowed full-year revenue guidance to $47.5M-$48.5M, raised gross-margin guidance to 62%-64%, ended with $8.3M cash, and expects positive adjusted EBITDA. It acquired a connected monitoring technology asset and shifted some FDA oncology timing.

KORU Medical Systems reported Q2 2026 revenue up 18% and first positive net income since 2019, with domestic revenue up 12% and international revenue up 59%. It withdrew a US FDA 510(k) for Phesgo, narrowed FY revenue guidance to $47.5M-$48.5M, raised gross margin to 62%-64%, and expects positive adjusted EBITDA in 2026.

KORU Medical Systems, Inc. (KRMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance MAHWAH, NJ – August 5, 2026 – KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development,

The Direxion Daily South Korea Bull 3X Shares (KORU) ETF fell nearly 20% overnight, heading for its worst monthly decline. SK Hynix Inc. (SKHY) reported Q2 earnings below expectations, with revenue at 79.32 trillion won and operating profit at 60.54 trillion won, both missing forecasts. SK Hynix shares dropped over 8% in the U.S. and 14% in South Korea, impacting the KOSPI index.